WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
1. (WO1998055138) PHARMACEUTICAL COMPOSITION CONTAINING TRANSFER FACTOR FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND REGRESSIVE BEHAVIOURAL DISORDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/055138    International Application No.:    PCT/GB1998/001637
Publication Date: 10.12.1998 International Filing Date: 04.06.1998
Chapter 2 Demand Filed:    04.01.1999    
IPC:
A61K 38/19 (2006.01), G01N 33/569 (2006.01), G01N 33/68 (2006.01)
Applicants: ROYAL FREE HOSPITAL SCHOOL OF MEDICINE [GB/GB]; Rowland Hill Street, London NW3 2PF (GB) (For All Designated States Except US).
NEUROIMMUNO THERAPEUTICS RESEARCH FOUNDATION [US/US]; 1092 Boiling Springs Road, Spartanburg, SC 29303 (US) (For All Designated States Except US).
WAKEFIELD, Andrew, Jeremy [GB/GB]; (GB) (For US Only).
FUNDENBURG, Hugh [US/US]; (US) (For US Only)
Inventors: WAKEFIELD, Andrew, Jeremy; (GB).
FUNDENBURG, Hugh; (US)
Agent: STEBBING, Peter, John, Hunter; Ablett & Stebbing, Caparo House, 101-103 Baker Street, London W1M 1FD (GB)
Priority Data:
9711663.6 06.06.1997 GB
Title (EN) PHARMACEUTICAL COMPOSITION CONTAINING TRANSFER FACTOR FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND REGRESSIVE BEHAVIOURAL DISORDER
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT UN FACTEUR DE TRANSFERT SERVANT A TRAITER LA MALADIE INTESTINALE INFLAMMATOIRE ET LES TROUBLES DE DEVELOPPEMENT PROFOND
Abstract: front page image
(EN)The present invention concerns a pharmaceutical composition for the treatment of an MMR virus mediated disease comprising a soluble dialysed leucocyte extract comprising a transfer factor (TF) formed by the dialysis of virus-specific lymphocytes to a molecular weight filter cut-off of 12,500 disposed in a pharmaceutically acceptable carrier or diluent therefor.
(FR)L'invention concerne une composition pharmaceutique servant à traiter une maladie provoquée par un virus de ROR et contenant un extrait de leucocyte soluble dialysé comprenant un facteur de transfert (TF) produit par la dialyse de lymphocytes spécifiques au virus à un seuil de rétention moléculaire de 12.500 dans un véhicule ou un diluant acceptable sur le plan pharmaceutique.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU.
African Regional Intellectual Property Org. (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)